Skip to content
411 PRESS
WarningRecall #D-0243-2026Drug / Pharmaceutical

CareFusion 213 Recalls BD ChloraPrep" Triple Swabsticks

CareFusion 213, LLC · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29

Reason for Recall

Lack of Assurance of Sterlity

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

Nationwide within the United States

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. CareFusion 213, LLC initiated the recall on December 17, 2025 affecting 106,400 units. Lack of Assurance of Sterlity. The product was distributed nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact CareFusion 213, LLC for further instructions.

Independent news on labor, safety, and accountability.